Skip to main content
. 2016 Jul 21;128(11):1449–1457. doi: 10.1182/blood-2016-05-718643

Table 4.

DAAs used to treat HCV in 2016 and their most common side effects

DAAs and side effects
Sofosbuvir
 Fatigue and headaches
Simeprevir
 Fatigue,* headaches,* nausea,* rash (including photosensitivity), and pruritus
Daclatasvir*
 Fatigue, headaches, anemia, and nausea
Ombitasvir-paritaprevir-ritonavir, and dasabuvir
 Fatigue, nausea, pruritus, other skin reactions (eg, rash, erythema, and eczema), insomnia, and asthenia
Ledipasvir-sofosbuvir
 Fatigue, headache, and asthenia
Elbasvir-grazoprevir
 Fatigue, headache, nausea, and anemia
Sofosbuvir-velpatasvir
 Headache, fatigue, anemia, nausea, headache, insomnia, and diarrhea
*

Most common adverse reactions reported in combination with sofosbuvir and ribavirin.

Most common adverse reactions reported with in combination with pegylated IFN-alfa and ribavirin.

Most common adverse reactions reported in combination with ribavirin.